We confirmed one of the TAM and tumor-associated erythroid cell interactions from our ligand-receptor analysis by using FISH to localize VCAM1-expressing CD163+ TAMs that are adjacent to ITGA4-expressing tumor-associated erythroid cells (Fig. 4e)24. Here, CD163 is linked to neoplasm.